Could a probiotic mix calm your IBS? new study seeks answers

NCT ID NCT07235228

Recruiting now Symptom relief Sponsor: The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a daily synbiotic supplement (Vivatlac) can change the gut bacteria of people with irritable bowel syndrome (IBS). Twenty adults with moderate to severe IBS will take either the supplement or a placebo for 12 weeks. Researchers will compare stool samples to see if the supplement shifts the types of bacteria in the gut.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vivatlac Synbiotic (a mix of nine probiotic bacteria strains)
What this could lead to: If it works, this could point toward a dietary supplement that eases IBS symptoms by improving gut bacteria balance.
What could go wrong: This is a very small early trial with only 20 participants, so results may not apply widely. The supplement may not change gut bacteria or symptoms significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME

Contacts and locations

Locations

State Hospital Jarocin
RECRUITING

Jarocin, 63-200, Poland
State Hospital Jarocin
RECRUITING

Jarocin, 63-200, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.